A novel HSP90 modulator with selective activity against thyroid cancers in vitro
about
Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cellsA novel RET inhibitor with potent efficacy against medullary thyroid cancer in vivo.Antiproliferative withanolides from several solanaceous species.Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and ApigeninMitogen/extracellular signal-regulated kinase kinase-5 promoter region polymorphisms affect the risk of sporadic colorectal cancer in a southern Chinese populationElectromagnetic fields at 2.45 GHz trigger changes in heat shock proteins 90 and 70 without altering apoptotic activity in rat thyroid glandThyroid Hormones, Autoantibodies, Ultrasonography, and Clinical Parameters for Predicting Thyroid Cancer.Exposure to non-ionizing radiation provokes changes in rat thyroid morphology and expression of HSP-90Novel withanolides target medullary thyroid cancer through inhibition of both RET phosphorylation and the mammalian target of rapamycin pathway.HSP90AB1: Helping the good and the bad.The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line.Withaferin A and its potential role in glioblastoma (GBM).Withanolides are potent novel targeted therapeutic agents against adrenocortical carcinomas.Natural withanolide withaferin A induces apoptosis in uveal melanoma cells by suppression of Akt and c-MET activation.Effects of endocrine therapy on the prognosis of elderly patients after surgery for papillary thyroid carcinoma.Discovering a Reliable Heat-Shock Factor-1 Inhibitor to Treat Human Cancers: Potential Opportunity for Phytochemists.
P2860
Q34042070-6F014756-159C-40B4-AAE3-9EF318DB728CQ34153520-0184220C-9593-4980-A640-DE1B355F1716Q34254455-DA2DD5D4-D985-43F6-93A3-CBBAF52201FDQ35784584-81DFBA55-01E6-46FA-9258-CA30DDA2E7D5Q35823884-BBF56F82-C11B-48BE-B286-ABB29BC7524EQ36425704-524E339B-B5F9-4E62-B8D5-9DB7E1B3265EQ36969850-62CA38AE-7123-4022-8C77-2C8B094BC3C1Q37071425-95DCD590-986C-4E42-A62A-BD649F102330Q37711241-1A4DA11A-C9E7-4B2B-9CB6-D37A0DECA56CQ38584468-539E5FD0-076B-4F5B-A61E-F746221FA42BQ38771103-5E02F64C-A393-4EE8-AF30-C8EF74F74DC4Q39006090-52B14339-77A9-4FF1-8E23-C9B6FEAA458CQ39203872-F1897AC0-E749-412F-8F01-93667329AB5EQ39369078-16C4B097-9C71-4B64-B192-CBB13101F0A3Q41286008-5C387B0C-66A0-4CFF-A37A-66B112781302Q55258376-C652913F-701E-4A34-B81B-6867233E2093
P2860
A novel HSP90 modulator with selective activity against thyroid cancers in vitro
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
A novel HSP90 modulator with selective activity against thyroid cancers in vitro
@en
A novel HSP90 modulator with selective activity against thyroid cancers in vitro.
@nl
type
label
A novel HSP90 modulator with selective activity against thyroid cancers in vitro
@en
A novel HSP90 modulator with selective activity against thyroid cancers in vitro.
@nl
prefLabel
A novel HSP90 modulator with selective activity against thyroid cancers in vitro
@en
A novel HSP90 modulator with selective activity against thyroid cancers in vitro.
@nl
P2093
P2860
P1433
P1476
A novel HSP90 modulator with selective activity against thyroid cancers in vitro
@en
P2093
Abbas Samadi
Barbara N Timmermann
Gemma O'Donnell
Mark S Cohen
Rithwi Mukerji
Xiaqin Tong
P2860
P304
P356
10.1016/J.SURG.2009.09.028
P407
P577
2009-12-01T00:00:00Z